JBIO Jade Biosciences, Inc.: institutional ownership and insider trading
156 funds reported holding $1.70B of Jade Biosciences, Inc. in their latest 13F filings; in Q2 2026 funds net bought $442M, with 50 new positions and 16 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market.
JBIO revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$55.8M, EPS -0.76
- Quarter ended Mar 31, 2026: revenue n/a, net income −$40.4M, EPS -0.57
- Quarter ended Dec 31, 2025: revenue n/a, net income −$31.9M, EPS 10.25
- Quarter ended Sep 30, 2025: revenue n/a, net income −$25.2M, EPS -0.48
Famous investors holding JBIO
- Ken Griffin (Citadel Advisors): $20.7M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $6.99M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $1.64M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $1.14M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $1.01M, 0.0% of the portfolio
Largest institutional holders of JBIO
- FMR LLC — $203M
- Jupiter Topco LLC — $139M
- Fairmount Funds Management LLC — $101M
- RA CAPITAL MANAGEMENT, L.P. — $81.6M
- VR Adviser, LLC — $71.6M
- Bellevue Group AG — $67.9M
- Paradigm Biocapital Advisors LP — $63.5M
- BlackRock, Inc. (BLK) — $62.2M
- FRANKLIN RESOURCES INC (BEN) — $62.0M
- STATE STREET CORP (STT, STT-PG) — $51.9M
Recent JBIO insider trades
- May 16, 2025: Frohlich Tom bought 6,000 shares ($44.4K)
5%+ owners
- Fairmount Funds Management LLC: 20.0% (Schedule 13D/A, filed Jun 9, 2026)
- JANUS HENDERSON GROUP Ltd.: 10.6% (Schedule 13G/A, filed Jul 8, 2026)
- Venrock Healthcare Capital Partners III, L.P.: 8.3% (Schedule 13G/A, filed Aug 14, 2026)
- JANUS HENDERSON GROUP PLC: 6.3% (Schedule 13G/A, filed May 15, 2026)
- Paradigm BioCapital Advisors LP: 5.1% (Schedule 13G, filed Jul 17, 2026)
- Bellevue Group AG: 5.0% (Schedule 13G/A, filed Aug 14, 2026)
Who owns the most JBIO stock?
The largest institutional holders of Jade Biosciences, Inc. in the latest 13F filings are FMR LLC ($203M), Jupiter Topco LLC ($139M), Fairmount Funds Management LLC ($101M).
Are insiders buying or selling JBIO?
No open-market insider buys or sells of Jade Biosciences, Inc. were reported in the last 12 months.
Which famous investors own JBIO?
Ken Griffin, Izzy Englander, Renaissance Technologies, D. E. Shaw, Two Sigma.
Which ETFs hold JBIO?
11 ETFs and mutual funds hold it among their top 100 positions, including FRCSX, JAGLX, JGLYX, FBTAX.